Literature DB >> 23000203

Complex metabolic and skeletal changes in men taking long-term androgen deprivation therapy.

Stanislav Ziaran1, Frederico M Goncalves, Jan Breza Sn.   

Abstract

BACKGROUND: The objective of this study was to assess complex skeletal and metabolic changes in a single cohort of PCa patients taking long-term ADT. PATIENTS AND METHODS: Ninety-five patients with locally advanced PCa (mean age 73.3 ± 6.2 years) were treated with ADT for 24 months. Body mass index (BMI), waist-to-hip ratio (WHR), lipid profile, serum fasting glucose (SFG), and bone mineral density (BMD) of lumbar spine (L1-L4), femoral neck, and total hip BMD were examined at the baseline, and then every 12 months. These measurements were also made to the control group of 88 patients (mean age, 71.9 ± 6.7 years).
RESULTS: After 12 months of ADT, BMI, WHR, low-density lipoprotein, overall cholesterol, and SFG increased significantly; and total hip BMD and BMD L1-L4 decreased significantly in the study group. After 24 months of ADT, BMI, WHR, and SFG increased significantly. BMD was significantly lower in L1-L4, femoral neck, and total hip. Four patients (4.2%) were diagnosed with new onset diabetes. Overall, the incidence of fractures after 24 months of ADT was 7-fold higher in the study group.
CONCLUSION: ADT leads into unfavorable changes in body composition, unfavorable lipoprotein profile, increase in SFG level and decrease in BMD. The incidence of fractures was 7-fold higher in the study group.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23000203     DOI: 10.1016/j.clgc.2012.08.005

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN: 1558-7673            Impact factor:   2.872


  4 in total

Review 1.  Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy.

Authors:  Annie-Claude M Lassemillante; Suhail A R Doi; John D Hooper; John B Prins; Olivia R L Wright
Journal:  Endocrine       Date:  2015-01-31       Impact factor: 3.633

Review 2.  Androgen-deprivation therapy and bone loss in prostate cancer patients: a clinical review.

Authors:  Marc Bienz; Fred Saad
Journal:  Bonekey Rep       Date:  2015-06-24

3.  Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part One.

Authors:  Joseph Pizzorno; Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-04

4.  Lipid Status During Combined Treatment in Prostate Cancer Patients.

Authors:  Edyta Wolny-Rokicka; Andrzej Tukiendorf; Jerzy Wydmański; Małgorzata Ostrowska; Agnieszka Zembroń-Łacny
Journal:  Am J Mens Health       Date:  2019 Sep-Oct
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.